Early detection of ADHD in drug and alcohol settings and, conversely, substance use disorders within mental health settings is critical to avoid the morbidity associated with coexisting ADHD and substance use disorders.
In this webinar, A/Prof. Emma Sciberras is joined by Prof. Edward Ogden to discuss how and when to initiate treatment for ADHD in patients with a history of drug and alcohol misuse.
Professor Ogden has been studying the impact of drugs and alcohol for over 40 years. His research interests focus on the role of alcohol and drugs in traffic safety, and the development of treatments for alcohol and drug abuse. He is currently working with academic and clinical colleagues to form a centre for ADHD research with a particular interest in ADHD and Substance Use Disorder.
Professor Ogden will share his experience and knowledge of the impacts of drug and alcohol misuse and how and when to initiate treatment for ADHD in individuals with a history of drug and alcohol misuse.
About Prof. Edward Ogden
Professor Edward Ogden PSM is the Principal Research Fellow – Clinical Trials, Centre for Mental Health and Brain Sciences, Swinburne University, a staff specialist in addiction medicine at Austin Hospital in Melbourne and the Addiction Medicine Specialist at Goulburn Valley Health in rural Victoria.
He is a Fellow of the Royal Australian College of General Practitioners, a Fellow of the Chapter of Addiction Medicine of the Royal Australian College of Physicians and a Fellow of the Faculty of Clinical Forensic Medicine of the Royal College of Pathologists of Australasia.
Prof. Ogden was awarded the Public Service Medal for services to Forensic Medicine on Australia Day 2005. He was also awarded the Widmark Medal by the International Council on Alcohol Drugs and Traffic Safety for his outstanding, meritorious contribution to road safety.
